Company / SG&A Expense
Regenerative Medical Technology Group Inc. SG&A Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.1M
FY2025
5-year range
$149.4K / $8.2M
FY2021-FY2025
Trend
+40.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 8 years, ranging from $29,866 in FY2020 to $8M in FY2022.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +106.4%.
Increased from $752,527 to $1M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -48.5%
- 5-Year CAGR
- +106.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +106.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 40.3% year-over-year.
- Peak sg&a expense was recorded in FY2022.
- Lowest sg&a expense in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +40.3% |
| FY2024 | $798.3K | +6.1% |
| FY2023 | $752.5K | -90.8% |
| FY2022 | $8.2M | +5389.6% |
| FY2021 | $149.4K | +400.1% |
| FY2020 | $29.9K | -4.8% |
| FY2019 | $31.4K | -27.2% |
| FY2018 | $43.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026